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cEREBROPROTEcTION By GERmANIUm cOORdINATION cOmPOUNds 
IN ExPERImENTAL AcUTE GLOBAL BRAIN IschEmIA
V. D. Lukianchuk1, I. I. Seifullina2, O. E. Martsinko2, O. O. Shevchuk3 
Background. Stroke is among the leading causes of death and disability worldwide with rising incidence 
among young people today. This is the third most common cause of disability-adjusted life-years worldwide
Objective. The present study evaluated the cerebroprotective action of coordination compounds of 
germanium with underlying global cerebral ischemia in rats.
Methods. Global cerebral infarction was induced by bilateral common carotid artery occlusion. For primary 
screening we used numerous bis(citrate) germanates (stannates) compounds, which contained different metals: 
OL1-8, and VITAGERM-1,2,3 and 4. All germanium complexes used were injected intraperitoneally (1 % aqueous 
solution at a dose of 50 and 100 mg/kg in 35 min after bilateral common carotid artery occlusion). Piracetam 
was used as a reference drug. Criteria of cerebroprotection efficacy survival of rats (%), ET50 (median effective 
time), observational Irwin’s test.
Results. Almost all bis(citrate) germanates (stannates), which contained different metals, possessed anti-
ischemic activity of different intensity. The exceptions were cobalt-containing OL-6 and OL-2 compounds. The 
most significant efficac of all investigated indices (which exceeded even reference drug) was evidenced for 
VITAGERM-1 – a coordination compound of germanium, diethylenetriaminepentaacetic acid and lithium. 
Conclusions. Results of our experiments are the substitution for further more profound pharmacological 
investigation of VITAGERM-1 for stroke cerebroprotection and its implementation into clinics.
KeY WoRdS: global brain ischemia; germanium coordination compounds; screening.
Introduction
Today stroke is in the top 10 causes of death 
in the world. It maintains the position as the 
leading killer, and accounts for more than 
6 million deaths annually [1]. In Ukraine, it is 
near 100 000 cases each year, and almost 40 000 
of them are fatal [2]. 
Risk of stroke is rising in direct proportion 
to the patient’s age. However, it is observed its 
rising incidence among young people up to 40 
years old in age [2, 3]. Stroke affects men and 
women equally and causes major social and 
economic burdens to society: 80 % of survivors 
are disabled until the end of life [4]. This is the 
third most common cause of disability-adjusted 
life-years worldwide [4, 5]. More than 80 % of 
all strokes are ischemic and characterized by 
occlusion of brain vessel of thrombi or embolus. 
the aim of the study is to find the effective 
cerebroprotector among original synthesized 
coordination compounds of germanium in the 
experimental model of acute global cerebral 
ischemia.
Methods
experiments were performed on white 
inbred rats, males and females, 180–220 g of 
body weight. Acute brain ischemia was modeled 
by bilateral occlusion of both common carotid 
arteries before its bifurcation to external and 
internal branches under thiopental general 
anesthesia. 
All animals’ procedures were carried out 
according to the rules and requirements of 
European Convention for the Protection of 
Vertebrate animals used for experimental and 
other Scientific Purposes as well as eu direc-
tives 2010/63/EU. 
For primary screening we used numerous 
bis(citrate)germanates (stannates) compounds, 
which contained different metals: magnesium 
bis(citrate) germanate (germacit), mangan 
bis(citrate) germanate (Ol1), cobalt bis(citrate) 
germanate (Ol2), nickel bis(citrate) germanate 
(Ol3), zinc bis(citrate) germanate (Ol4), mag-
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nesium bis(citrate) stannate (Ol5), cobalt 
bis(citrate) stannate (Ol6), nickel bis(citrate) 
stannate (Ol7), zinc bis(citrate)  stannate (Ol8), 
vITAGERM-1 (coordination compound of 
germanium, diethylenetriaminepentaacetic 
acid and lithium), vITAGERM-2 (coordination 
compound of germanium, di ethyl enetri ami-
nepentaacetic acid and sodium), vITAGERM-3 
(coordination compound of germanium, di-
ethylenetriaminepentaacetic acid and potas-
sium), vITAGERM-4 (coordination compound of 
germanium, diethyl ene tri aminepentaacetic 
acid and magnesium). All the compounds were 
primarily synthesized in the laboratory of 
Department of General Chemistry and Polymers, 
I. Mechnikov Odesa National University, headed 
by prof. I. Seifullina. 
all used germanium complexes were 
administered to rats at the doses according to 
the results of our previous studies [6, 7]. We 
injected them intraperitoneally in the form of 
1 % aqueous solution at a dose of 50 and 
100 mg/kg in 35 min after bilateral common 
carotid artery occlusion. 
As a comparator (reference) drug, Piracetam 
medication was used (Farmak, Ukraine, 20 % 
solution in 5 ml ampules). It was injected 
intraperitoneally at a dose of 350 mg/kg in 
30 min after ischemia. The rats of control group 
(ischemia without any correction) got equivalent 
dose of saline. 
Criteria of cerebroprotector activity of the 
studied compounds were: survival of rats (%)
each hour during the first 12 hours, then on the 
24th, 48th and 72nd hours of ischemia; monitoring 
the clinical signs for ET50 (median effective time – 
the time required for a half as organisms in a 
toxicity test to reveal the nonlethal response). 
It was evaluated to be ET50=f(N/2) by interpolation 
of data of lethality time to mathematical 
function T=f(N), where T is the time of animals 
death, N – the number of animals. Neurological 
status was assessed by Irwin’s test in the model 
of acute brain ischemia and administration of 
germanium compounds.  The primary 
observation test was used for rodents to assess 
acute toxicity of a test agent and its effects on 
behavior and physiological function [8, 9].
Statistical analysis. Statistical analysis of 
animals’ survival have been carried out using 
the nonparametric criterion fisher’s exact test 
and average time of lifespan by use of t-criterion 
of Students’ test. All data were presented as M 
(mean) ± m (standard error). A probability level 
(p value) of less than 0.05 was considered to be 
statistically significant. 
Results 
The results obtained in the screening model 
of global brain ischemia are presented in the 
Table 1. Almost all bis(citrate) germanates 
(stannates), which contained different metals, 
possessed anti-ischemic activity of different 
intensity. the exception was the ol-6 compound, 
which comprised cobalt. Even at the dose of 
50 mg per kg in this group during the first hour 
of occlusion of aa. carotica communes the rate 
of rats survival was only 28.5 % opposite to 
100 % in the control group. In addition, the 
other cobalt-containing compound Ol-2 proved 
very low efficacy for cerebroprotection. 
As for the results in Table 1, the most 
significant efficacy on the 48th hour of the 
experiment was evidenced for VitageRM-1 – 
a coordination compound of germanium, 
diethylenetriaminepentaacetic acid and lithium. 
The animals’ survival in this group was 57.1 % 
compared to 100 % lethality in the control 
group. It is important that the anti-ischemic 
activity of VitageRM-1 exceeded even the effect 
of reference drug Piracetam.
To estimate the obtained screening results 
more profoundly and detail, we suggested and 
used in our experiment the index of median 
effective time ET50. According to the results 
presented in Table 1, ET50 for group of rats 
administered with vITAGERM-1 was 53.31±2.77. 
It was in 7.5, 3.0 times better compared to the 
control and reference group respectively. 
At the same time to make an all-round 
comparison analysis of the results of screening 
series we assessed clinical signs of acute 
ischemia: neurological status of rats, which got 
the different types of germanium compounds. 
All data are presented in Table 2.
The rats with stroke, on the model we chose, 
experienced the severe clinical signs of global 
ischemia. The animals of control group after 
occlusion of both carotid arteries became less 
alert and more passive. It was proved by the 
indices of emotional condition: grooming 
decreased up to 0 points, vocalization increased 
up to 1.4. The tonus of limbs also diminished, 
ataxia signs increased up to 2.9 points. the 
character of these neurological changes 
testified quite a deep injury of brain cortex 
because of global ischemia. It resulted in the 
disruption of motor activity in the control group 
rats: suppression of reactions to touch and 
knock up to 1.5 and 1.9 points respectively. 
Brain ischemia also strengthened the tremor 
up to 2.3 points. The suppression of ptosis 
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frequency of urination and defecation was 
evidenced in comparison to the indices of 
healthy group. 
the next stage of our experiment was to 
estimate the neurological and behavioral profile 
of rats under the influence of germanium 
compounds in global brain ischemia model. The 
most efficient compound was VitageRM-1 again 
(tables 2.1 and 2.2). the significant increase of 
alertness up to 3.0 points and decreasing of 
expressiveness of passivity by 41.0 % was fixed 
in this group compared to the control rats. This 
investigated compound increased the grooming 
and normalized the vocalization. Administration 
of VitageRM-1 led to absence of ataxia and 
increase of extremities tonus up to 3.3 points 
that was nearly the same as the indices of the 
intact rats. Responses to touch and knock 
intensified also up to 3.6 and 3.5 points 
respectively in comparison to the control.
We noticed total positive effects of this 
germanium compounds in prevention of 
tremor, urination and defecation; the ptosis 
rate increased up to 2.2 points. 
Discussion
the pathophysiology of stroke is complex, 
and involves inflammatory pathways, oxidative 
damage, apoptosis, energy deficiency etc. the 
main goal of treatment is to preserve tissues in 
ischemic penumbra, where perfusion is de-
creased but sufficient to stave off infarction, 
and save the neurons (neuroprotection) [4, 5]. 
Ischemic stroke and its consequences is a 
major public health problem. In spite of huge 
number of medications to treat it, we still have 
no perfect one according to the present 
requirements of safety and efficacy. that is why 
the search and investigation of newly synthe-
sized organic and other compounds with capa-
bility for stroke protection is an actual challenge 
and target for chemists, pharmacologists, 
physicians and health professionals.
Numerous bis(citrate) germanates (stan-
nates) compounds with wide spectrum of thera-
peutic activity are synthesized and investigated 
today. our previous experiments proved its low 
toxicity to warm-blooded species [10, 11, 12]. 
Use of the rodent models is recommended and 
approved by different researches for screening 
and investigating of promising compounds to 
prevent and treat ischemic brain lesions [13]. In 
the screening series in the model of global brain 
ischemia (via occlusion of both common carotid 
arteries before its bifurcation), it was determined 
that almost all compounds had potency for 
stroke protection. Such criteria as survival and 
median effective time plus Irwin’s test results 
were adequate to evaluate it [14, 15]. Piracetam 
was used as a reference drug [16].
Among all  investigated bis(citrate)
germanate (stannates) compounds, which 
contained different metals, the most potent 
anti-ischemic activity was possessed by 
coordination compound of germanium, 
diethylenetriaminepentaacetic acid and lithium 
coded as vITAGERM-1. It was a leader among 
the germanium compounds according to the 
analyses of the indices of survival and lifespan 
of rats from the moment of occlusion of 
coronary arteries.
Such positive effects were manifested by the 
highest level of survival and the most favorable 
clinical course of cerebrovascular blood 
circulation. Median effective time ET50 in this 
group exceeded in 7.5 and 3.0 times the index 
of control and reference group respectively. We 
noticed total positive effects of this germanium 
compounds in prevention of disorders of 
behavioral, neurological and autonomic profiles 
of rats. Therefore, we concluded the prominent 
improvement of clinical course of acute brain 
ischemia under the vitagerm-1 impact.
We suppose that the presence of the cobalt 
in structure of Ol-2 and Ol-5 molecules is 
responsible for animals lethality during the first 
hour after the disorder development. low 
efficacy of these germanium compounds could 
be explained by the fact that this metal is a 
cytochrome P450 inhibitor. The cytochromes 
P450 (CyPs) enzyme family are crucial in 
processes of detoxification of the organism, 
and suppression of its activity is one of the most 
possible causes of high lethality in cases of 
experimental global brain ischemia [17]. 
Conclusions 
Almost all bis(citrate) germanates (stan-
nates), which contained different metals, 
possessed anti-ischemic activity of different 
intensity. the exceptions were cobalt-containing 
ol-6 and ol-2 compounds. the most expressive 
efficacy for all investigated indices (which 
exceeded even the reference drug) proved for 
vITAGERM-1 – a coordination compound of 
germanium, diethylenetriaminepentaacetic 
acid and lithium.
the results of our experiments are sugges-
ted for the substitution for further deeper 
pharmacological investigation of vITAGERM-1 
for stroke cerebroprotection, and its imple-
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ПОШУК ЦЕРЕБРОПРОЕКТОРІВ СЕРЕД КООРДИНАЦІЙНИХ СПОЛУК 
ГЕРМАНІЮ НА МОДЕЛІ ІШЕМІЧНОГО ІНСУЛЬТУ
В. Д. Лук’янчук1, І. Й. Сейфулліна2, О. Е. Марцинко2, О. О. Шевчук3 
1 – ДУ «ІНСТИТУТ ФАРМАКОЛОГІЇ ТА ТОКСИКОЛОГІЇ НАМН УКРАЇНИ», КИЇВ, УКРАЇНА
2 –  ОДЕСЬКИЙ НАЦІОНАЛЬНИЙ УНІВЕРСИТЕТ ІМЕНІ І. І. МЕЧНИКОВА, ОДЕСА, УКРАЇНА 
3 – ТЕРНОПІЛЬСЬКИЙ ДЕРЖАВНИЙ МЕДИЧНИЙ УНІВЕРСИТЕТ ІМЕНІ І. Я. ГОРБАЧЕВСЬКОГО, ТЕРНОПІЛЬ, 
УКРАЇНА
Вступ. Інсульт залишається однією з  провідних причин смертності та інвалідності в усьому світі, однак 
спостерігається зростання захворюваності серед молоді. 
Мета дослідження – скринінгове дослідженння церебропротекторної дії координаційних сполук германію на 
моделі гострої ішемії у щурів.
Методи. Гостру ішемію моделювали двосторонньою оклюзією загальної сонної артерії. Для первинного скринінгу 
використовувалися сполуки біс(цитрато)германати (станати), що містили різні метали: OL1-8, VITAGERM-1,2,3 та 
4. Усі використовувані комплекси германію вводили внутрішньочеревно (1% водного розчину при дозі 50 і 100 мг/кг
через 35 хв після двосторонньої загальної оклюзії сонної артерії). Пірацетам використовували в якості референс 
препарату. Критерії ефективності церебропротекції: виживання щурів (%), ЕТ50 (середній час загибелі 50% тварин), 
тест Ірвіна. 
Результати. Результати, отримані на скринінговій моделі тотальної ішемії головного мозку, показали, що 
практично всі різнометальні біс(цитрато) германати (станати) володіють антиішемічною активністю різної 
інтенсивності. Виняток становили сполуки, що містять кобальт OL-6 і OL-2. Найбільш значима ефективність всіх 
досліджених показників (які перевищували навіть еталонний препарат) була підтверджена для VITAGERM-1 – 
координаційного з’єднання германію, діетилентриамінпентаоцтової кислоти і літію.
Висновки. Результати наших експериментів слугуют підгрунтям для подальшого вивчення сполуки VITAGERM-1 
у якості церебропротектора та її впровадження в клінічну практику.
КЛЮЧОВІ СЛОВА: тотальна ішемія головного мозку; координаційні сполуки германію; скринінг.
